Probucol-holdigt lægemiddel med forøget biotilgængelighed

Probucol-holdigt lægemiddel med forøget biotilgængelighed

A pharmaceutical composition of probucol that both enhances bioavailability of the drug and reduces plasma drug level variability in a patient population comprising a therapeutically effective amount of probucol dissolved in a propylene glycol ester of fatty acids wherein the fatty acids are selecte...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: NEDDERMEYER, MELISSA P, BASSLER, KENNETH G, DEEPAK, PHADKE S
Format: Patent
Sprache:dan
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator NEDDERMEYER, MELISSA P
BASSLER, KENNETH G
DEEPAK, PHADKE S
description A pharmaceutical composition of probucol that both enhances bioavailability of the drug and reduces plasma drug level variability in a patient population comprising a therapeutically effective amount of probucol dissolved in a propylene glycol ester of fatty acids wherein the fatty acids are selected from the group consisting of the fatty acids represented by CxH2xO2, wherein x is 4, 6, 8, 10, 12, 14, 16.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DK0563112TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DK0563112TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DK0563112TT33</originalsourceid><addsrcrecordid>eNrjZLAJKMpPKk3Oz9HNyM9JyUwvUcg5vCw9NTczJSU1RyE3NUUhLb_o8I701BKFpMz8ksyc9MPL8tJTczLTM1JTeBhY0xJzilN5oTQ3g6Kba4izh25qQX58anFBYnJqXmpJvIu3gamZsaGhUUiIsTExagAF4jKX</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Probucol-holdigt lægemiddel med forøget biotilgængelighed</title><source>esp@cenet</source><creator>NEDDERMEYER, MELISSA P ; BASSLER, KENNETH G ; DEEPAK, PHADKE S</creator><creatorcontrib>NEDDERMEYER, MELISSA P ; BASSLER, KENNETH G ; DEEPAK, PHADKE S</creatorcontrib><description>A pharmaceutical composition of probucol that both enhances bioavailability of the drug and reduces plasma drug level variability in a patient population comprising a therapeutically effective amount of probucol dissolved in a propylene glycol ester of fatty acids wherein the fatty acids are selected from the group consisting of the fatty acids represented by CxH2xO2, wherein x is 4, 6, 8, 10, 12, 14, 16.</description><edition>6</edition><language>dan</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1995</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19950410&amp;DB=EPODOC&amp;CC=DK&amp;NR=0563112T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19950410&amp;DB=EPODOC&amp;CC=DK&amp;NR=0563112T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NEDDERMEYER, MELISSA P</creatorcontrib><creatorcontrib>BASSLER, KENNETH G</creatorcontrib><creatorcontrib>DEEPAK, PHADKE S</creatorcontrib><title>Probucol-holdigt lægemiddel med forøget biotilgængelighed</title><description>A pharmaceutical composition of probucol that both enhances bioavailability of the drug and reduces plasma drug level variability in a patient population comprising a therapeutically effective amount of probucol dissolved in a propylene glycol ester of fatty acids wherein the fatty acids are selected from the group consisting of the fatty acids represented by CxH2xO2, wherein x is 4, 6, 8, 10, 12, 14, 16.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1995</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAJKMpPKk3Oz9HNyM9JyUwvUcg5vCw9NTczJSU1RyE3NUUhLb_o8I701BKFpMz8ksyc9MPL8tJTczLTM1JTeBhY0xJzilN5oTQ3g6Kba4izh25qQX58anFBYnJqXmpJvIu3gamZsaGhUUiIsTExagAF4jKX</recordid><startdate>19950410</startdate><enddate>19950410</enddate><creator>NEDDERMEYER, MELISSA P</creator><creator>BASSLER, KENNETH G</creator><creator>DEEPAK, PHADKE S</creator><scope>EVB</scope></search><sort><creationdate>19950410</creationdate><title>Probucol-holdigt lægemiddel med forøget biotilgængelighed</title><author>NEDDERMEYER, MELISSA P ; BASSLER, KENNETH G ; DEEPAK, PHADKE S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DK0563112TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>dan</language><creationdate>1995</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>NEDDERMEYER, MELISSA P</creatorcontrib><creatorcontrib>BASSLER, KENNETH G</creatorcontrib><creatorcontrib>DEEPAK, PHADKE S</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NEDDERMEYER, MELISSA P</au><au>BASSLER, KENNETH G</au><au>DEEPAK, PHADKE S</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Probucol-holdigt lægemiddel med forøget biotilgængelighed</title><date>1995-04-10</date><risdate>1995</risdate><abstract>A pharmaceutical composition of probucol that both enhances bioavailability of the drug and reduces plasma drug level variability in a patient population comprising a therapeutically effective amount of probucol dissolved in a propylene glycol ester of fatty acids wherein the fatty acids are selected from the group consisting of the fatty acids represented by CxH2xO2, wherein x is 4, 6, 8, 10, 12, 14, 16.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language dan
recordid cdi_epo_espacenet_DK0563112TT3
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Probucol-holdigt lægemiddel med forøget biotilgængelighed
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T23%3A05%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NEDDERMEYER,%20MELISSA%20P&rft.date=1995-04-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDK0563112TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true